Literature DB >> 24217198

Rituximab maintenance therapy after autologous stem cell transplantation prolongs progression-free survival in patients with mantle cell lymphoma.

S Dietrich1, J Weidle1, M Rieger1, J Meissner1, A Radujkovic1, A D Ho1, P Dreger1, M Witzens-Harig1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24217198     DOI： 10.1038/leu.2013.332

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  10 in total

1.  Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial.

Authors:  Mathias J Rummel; Norbert Niederle; Georg Maschmeyer; G Andre Banat; Ulrich von Grünhagen; Christoph Losem; Dorothea Kofahl-Krause; Gerhard Heil; Manfred Welslau; Christina Balser; Ulrich Kaiser; Eckhart Weidmann; Heinz Dürk; Harald Ballo; Martina Stauch; Fritz Roller; Juergen Barth; Dieter Hoelzer; Axel Hinke; Wolfram Brugger
Journal:  Lancet       Date:  2013-02-20       Impact factor: 79.321

2.  Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG).

Authors:  Georg Lenz; Martin Dreyling; Eva Hoster; Bernhard Wörmann; Ulrich Dührsen; Bernd Metzner; Hartmut Eimermacher; Andreas Neubauer; Hannes Wandt; Hjalmar Steinhauer; Sonja Martin; Else Heidemann; Ali Aldaoud; Reza Parwaresch; Joerg Hasford; Michael Unterhalt; Wolfgang Hiddemann
Journal:  J Clin Oncol       Date:  2005-01-24       Impact factor: 44.544

3.  Rituximab purging and/or maintenance in patients undergoing autologous transplantation for relapsed follicular lymphoma: a prospective randomized trial from the lymphoma working party of the European group for blood and marrow transplantation.

Authors:  Ruth Pettengell; Norbert Schmitz; Christian Gisselbrecht; Graeme Smith; William N Patton; Bernd Metzner; Dolores Caballero; Herve Tilly; Jan A Walewski; Isabelle Bence-Bruckler; Bik To; Christian H Geisler; Rik Schots; Eva Kimby; Christian J Taverna; Tomás Kozák; Peter Dreger; Ruzena Uddin; Carmen Ruiz de Elvira; Anthony H Goldstone
Journal:  J Clin Oncol       Date:  2013-04-01       Impact factor: 44.544

4.  Treatment of older patients with mantle-cell lymphoma.

Authors:  H C Kluin-Nelemans; E Hoster; O Hermine; J Walewski; M Trneny; C H Geisler; S Stilgenbauer; C Thieblemont; U Vehling-Kaiser; J K Doorduijn; B Coiffier; R Forstpointner; H Tilly; L Kanz; P Feugier; M Szymczyk; M Hallek; S Kremers; G Lepeu; L Sanhes; J M Zijlstra; R Bouabdallah; P J Lugtenburg; M Macro; M Pfreundschuh; V Procházka; F Di Raimondo; V Ribrag; M Uppenkamp; M André; W Klapper; W Hiddemann; M Unterhalt; M H Dreyling
Journal:  N Engl J Med       Date:  2012-08-09       Impact factor: 91.245

5.  Patterns and outcome of relapse after autologous stem cell transplantation for mantle cell lymphoma.

Authors:  Sascha Dietrich; Blanca Tielesch; Michael Rieger; Maike Nickelsen; Christiane Pott; Mathias Witzens-Harig; Michael Kneba; Norbert Schmitz; Antony D Ho; Peter Dreger
Journal:  Cancer       Date:  2010-11-29       Impact factor: 6.860

6.  Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study.

Authors:  F Lefrère; A Delmer; F Suzan; V Levy; C Belanger; M Djabarri; B Arnulf; G Damaj; N Maillard; V Ribrag; M Janvier; C Sebban; R-O Casasnovas; R Bouabdallah; F Dreyfus; V Verkarre; E Delabesse; F Valensi; E McIntyre; N Brousse; B Varet; O Hermine
Journal:  Leukemia       Date:  2002-04       Impact factor: 11.528

7.  Immunochemotherapy with rituximab and overall survival in patients with indolent or mantle cell lymphoma: a systematic review and meta-analysis.

Authors:  Holger Schulz; Julia F Bohlius; Sven Trelle; Nicole Skoetz; Marcel Reiser; Thilo Kober; Guido Schwarzer; Michael Herold; Martin Dreyling; Michael Hallek; Andreas Engert
Journal:  J Natl Cancer Inst       Date:  2007-05-02       Impact factor: 13.506

8.  ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma.

Authors:  M Dreyling; C Thieblemont; A Gallamini; L Arcaini; E Campo; O Hermine; J C Kluin-Nelemans; M Ladetto; S Le Gouill; E Iannitto; S Pileri; J Rodriguez; N Schmitz; A Wotherspoon; P Zinzani; E Zucca
Journal:  Ann Oncol       Date:  2013-02-20       Impact factor: 32.976

9.  Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group.

Authors:  Christian H Geisler; Arne Kolstad; Anna Laurell; Niels S Andersen; Lone B Pedersen; Mats Jerkeman; Mikael Eriksson; Marie Nordström; Eva Kimby; Anne Marie Boesen; Outi Kuittinen; Grete F Lauritzsen; Herman Nilsson-Ehle; Elisabeth Ralfkiaer; Måns Akerman; Mats Ehinger; Christer Sundström; Ruth Langholm; Jan Delabie; Marja-Liisa Karjalainen-Lindsberg; Peter Brown; Erkki Elonen
Journal:  Blood       Date:  2008-07-14       Impact factor: 22.113

Review 10.  Mantle cell lymphoma: a retrospective study of 121 cases.

Authors:  H Samaha; C Dumontet; N Ketterer; I Moullet; C Thieblemont; F Bouafia; E Callet-Bauchu; P Felman; F Berger; G Salles; B Coiffier
Journal:  Leukemia       Date:  1998-08       Impact factor: 11.528
  10 in total
  13 in total

1.  Long-Term Results of High-Dose Therapy and Autologous Stem Cell Transplantation for Mantle Cell Lymphoma: Effectiveness of Maintenance Rituximab.

Authors:  Matthew G Mei; Thai M Cao; Lu Chen; Joo Y Song; Tanya Siddiqi; Ji-Lian Cai; Leonardo T Farol; Monzr M Al Malki; Amandeep Salhotra; Ibrahim Aldoss; Joycelynne Palmer; Alex F Herrera; Jasmine Zain; Leslie L Popplewell; Robert W Chen; Steven T Rosen; Stephen J Forman; Larry Kwak; Auayporn P Nademanee; Lihua E Budde
Journal:  Biol Blood Marrow Transplant       Date:  2017-07-18       Impact factor: 5.742

2.  The EBMT/EMCL consensus project on the role of autologous and allogeneic stem cell transplantation in mantle cell lymphoma.

Authors:  S Robinson; P Dreger; D Caballero; P Corradini; C Geisler; M Ghielmini; S Le Gouill; E Kimby; S Rule; U Vitolo; M Dreyling; O Hermine
Journal:  Leukemia       Date:  2014-07-18       Impact factor: 11.528

Review 3.  Recent advances in post autologous transplantation maintenance therapies in B-cell non-Hodgkin lymphomas.

Authors:  Narendranath Epperla; Timothy S Fenske; Parameswaran N Hari; Mehdi Hamadani
Journal:  World J Transplant       Date:  2015-09-24

4.  Blood and marrow transplant clinical trials network state of the Science Symposium 2014.

Authors:  Frederick R Appelbaum; Claudio Anasetti; Joseph H Antin; Harold Atkins; Stella Davies; Steven Devine; Sergio Giralt; Helen Heslop; Ginna Laport; Stephanie J Lee; Brent Logan; Marcelo Pasquini; Michael Pulsipher; Edward Stadtmauer; John R Wingard; Mary M Horowitz
Journal:  Biol Blood Marrow Transplant       Date:  2014-10-15       Impact factor: 5.742

5.  Outcomes and Utilization Trends of Front-Line Autologous Hematopoietic Cell Transplantation for Mantle Cell Lymphoma.

Authors:  Peter A Riedell; Mehdi Hamadani; Kwang W Ahn; Carlos Litovich; Guru Subramanian Guru Murthy; Frederick L Locke; Claudio G Brunstein; Reid W Merryman; Patrick J Stiff; Attaphol Pawarode; Taiga Nishihori; Mohamed A Kharfan-Dabaja; Alex F Herrera; Craig S Sauter; Sonali M Smith
Journal:  Transplant Cell Ther       Date:  2021-08-24

Review 6.  Post-autologous transplant maintenance therapies in lymphoid malignancies: are we there yet?

Authors:  N Epperla; T S Fenske; H M Lazarus; M Hamadani
Journal:  Bone Marrow Transplant       Date:  2015-08-17       Impact factor: 5.483

7.  Maintenance rituximab after autologous stem cell transplantation in patients with mantle cell lymphoma.

Authors:  S A Graf; P A Stevenson; L A Holmberg; B G Till; O W Press; T R Chauncey; S D Smith; M Philip; J J Orozco; A R Shustov; D J Green; E N Libby; W I Bensinger; J M Pagel; D G Maloney; Y Zhou; R D Cassaday; A K Gopal
Journal:  Ann Oncol       Date:  2015-09-07       Impact factor: 32.976

8.  Maintenance Therapies for Hodgkin and Non-Hodgkin Lymphomas After Autologous Transplantation: A Consensus Project of ASBMT, CIBMTR, and the Lymphoma Working Party of EBMT.

Authors:  Abraham S Kanate; Ambuj Kumar; Peter Dreger; Martin Dreyling; Steven Le Gouill; Paolo Corradini; Chris Bredeson; Timothy S Fenske; Sonali M Smith; Anna Sureda; Alison Moskowitz; Jonathan W Friedberg; David J Inwards; Alex F Herrera; Mohamed A Kharfan-Dabaja; Nishitha Reddy; Silvia Montoto; Stephen P Robinson; Syed A Abutalib; Christian Gisselbrecht; Julie Vose; Ajay Gopal; Mazyar Shadman; Miguel-Angel Perales; Paul Carpenter; Bipin N Savani; Mehdi Hamadani
Journal:  JAMA Oncol       Date:  2019-05-01       Impact factor: 31.777

9.  Maintenance therapy for untreated diffuse large B-cell lymphoma: a systematic review and network meta-analysis.

Authors:  Ting Yuan; Feng Zhang; Qingmin Yao; Yanxia Liu; Xiaojuan Zhu; Peng Chen
Journal:  Ther Adv Hematol       Date:  2021-05-29

Review 10.  Using the Promise of Sonodynamic Therapy in the Clinical Setting against Disseminated Cancers.

Authors:  Matthew Trendowski
Journal:  Chemother Res Pract       Date:  2015-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.